Notably, although iPSCs undergo extensive molecular changes during reprogramming and redifferentiation, it has been demonstrated that iPSC lines from AD donors continue to show increased ratio of Aβ42/Aβ40 and tau hyperphosphorylation in comparison to age-matched non-demented control iPSCs [177–180]. This evidence concerns the gene MAPT and Alzheimer disease.